A R T I C L E S
Hughes et al.
9, 7 Hz, 1H), 4.42 (ABX, dd, J ) 9, 7, Hz, 1H). 13C NMR (100 MHz,
CDCl3) δ: 14.06, 22.71, 29.67, 32.95, 34.70, 35.86, 73.61, 177.49. RD
(589 nm, 38.5 mg/mL CHCl3) ) +5.25
(major), 24.4 min (minor)) showed 93% ee. mp (CH2Cl2): 49-51 °C.
1H NMR (500 MHz, CDCl3) δ: 1.20 (d, J ) 6.8 Hz, 3H), 2.22 (ABX,
dd, J ) 16.7, 7.4 Hz, 1H), 2.55 (hextet, J ) 7.4 Hz, 1H), 2.72 (ABX,
dd, J ) 16.7, 8.4 Hz, 1H), 3.41 (ABX, dd, J ) 9.4, 6.4 Hz, 1H), 3.90
(ABX, dd, J ) 9.4, 7.6 Hz, 1H), 6.89 (ABX, dm, J ) 9.1 Hz, 2H),
7.47 (ABX, J ) 9.1 Hz, 2H). 13C NMR (300 MHz, CDCl3) δ: 19.42,
26.25, 40.61, 55.36, 56.26, 113.91, 121.72, 132.47, 156.43, 173.49.
IR (film, cm-1): 1688, 1513, 1397, 1266, 1034. Elemental analysis:
%C (calc.) ) 70.22, %C (found) ) 70.06, %H (calc.) ) 7.37, %H
(found) ) 7.31. RD (589 nm, 23.8 mg/mL CHCl3) ) -4.2.
(4S)-4-Propyltetrahydropyran-2-one. CuCl2‚2H2O (4.8 mg, 0.036
mmol, 5 mol %), (S)-BIPHEMP (24.2 mg, 0.0356 mmol, 5 mol %),
and t-BuONa (14.0 mg, 0.143 mmol, 20 mol %) were added to a
Schlenk tube which was then evacuated and charged with an argon
atmosphere. PMHS (86 µL, 1.426 mmol, 2 equiv) and toluene (0.5
mL) were added via syringe, and the mixture was stirred for 30 min.
Pentane (1 mL) was added, and the mixture was cooled to -40 °C. A
solution of 12a (100 mg, 0.713 mmol, 1 equiv) and dodecane (100
µL) in toluene (0.5 mL) was added via syringe, followed by t-AmOH
(156 µL, 1.43 mmol, 2 equiv). After 3 h, GC analysis showed complete
conversion, and the reaction was quenched by the addition of 10%
hydrochloric acid. The aqueous layer was extracted three times with
ether. The organic layers were combined, washed with brine, dried over
MgSO4, filtered, and concentrated to dryness. Purification by flash
chromatography (25% ethyl acetate/hexanes) afforded a mixture of the
title compound and an unidentified byproduct. A second flash chro-
matography (80% ether/hexanes) afforded the title compound as a
colorless liquid (71 mg, 70% yield). Chiral GC analysis (GTA column,
1 mL/min, 120 °C, 50 min, retention times: 41.3 min (major), 46.2
min (minor)) showed 86% ee. 1H NMR (300 MHz, CDCl3) δ: 0.88-
1.00 (m, 3H), 1.29-1.42 (m, 4H), 1.44-1.60 (m, 1H), 1.90-2.04 (m,
2H), 2.14 (ABX, dd, J ) 17, 10 Hz, 1H), 2.70 (ABX, ddd, J ) 17, 4,
1.5 Hz, 1H), 4.26 (ABX, ddd, J ) 11, 10, 3.5, 1H), 4.42 (ABX, ddd,
J ) 11, 5, 4 Hz, 1H). 13C NMR (300 MHz, CDCl3) δ: 14.16, 19.72,
29.06, 31.37, 36.74, 38.51, 68.78, 171.76. RD (589 nm, 23.8 mg/mL
CHCl3) ) -21.4.26
(4R)-4-Methyl-1-(4-methoxyphenyl)pyrrolidin-2-one. A solution
of 13 (50 mg, 0.267 mmol, 1 equiv) and i-PrOH (82 µL, 1.1 mmol, 4
equiv) in THF (0.50 mL) was added to a 0 °C slurry of CuCl2‚2H2O
(1.8 mg, 0.013 mmol, 5 mol %), (S)-p-tol-BINAP (9.1 mg, 0.013 mmol,
5 mol %), t-BuONa (5.2 mg, 0.053 mmol, 20 mol %), and PMHS (64
µL, 1.1 mmol, 4 equiv) in c-hexane (0.50 mL). The mixture was stirred
at 0 °C for 1 h. The reaction was quenched by the addition of 10%
hydrochloric acid, and the aqueous layer was extracted three times with
ethyl acetate. The organic layers were combined, washed with brine,
dried over MgSO4, filtered, and concentrated to dryness. Purification
by flash chromatography (70% ethyl acetate/hexanes) afforded the title
compound as a white crystalline solid (48 mg, 95%). Chiral HPLC
analysis (Daicel Chiralpak OB-H column (0.46 cmØ × 25 cm), 0.5
mL/min, 40% i-PrOH/hexane, 254, 280 nm, retention times: 18.4 min
(4R)-4-(4-Fluorophenyl)-1-(4-methoxyphenyl)piperidin-2-one (22).
CuCl2 (13.3 mg, 0.0992 mmol, 2.5 mol %) and t-BuONa (19.1 mg,
0.198 mmol, 5 mol %) were added to a mixture of 21 (1.18 g, 3.97
mmol, 1.0 equiv), (R)-p-tolBINAP (13.5 mg, 0.0198 mmol, 0.5 mol
%), PMHS (3.81 mL, 63.5 mmol, 16 equiv), and t-AmOH (6.95 mL,
63.5 mmol, 16 equiv) in fluorobenzene (8 mL). After 45 min, 10%
hydrochloric acid was added, and the mixture was extracted three times
with ethyl acetate. The organic layers were combined, washed with
brine, dried over MgSO4, filtered, and concentrated to dryness. The
residue was purified by flash chromatography (60% f 100% ethyl
acetate/hexanes) to afford the title compound as a crystalline solid (1.00
g, 89%, based on 95% pure starting material). Chiral HPLC analysis
(Daicel Chiralpak OD column (0.46 cmØ × 25 cm), 1.0 mL/min, 25%
i-PrOH/hexane, retention times: 19.4 min (minor), 22.3 min (major))
showed 90% ee. mp (Et2O): 183-186 °C. 1H NMR (300 MHz, CDCl3)
δ: 2.02-2.27 (m, 2H), 2.64 (ABX, dd, J ) 17, 11 Hz, 1H), 2.86 (ABX,
ddd, J ) 17, 5, 2 Hz, 1H), 3.18-3.30 (m, 1H), 6.62 (ABX, ddd, J )
12, 5, 4 Hz, 1H), 3.68-3.83 (m, 1H), 3.80 (s, 3H), 6.92 (ABX, dt, J
) 9, 2 Hz, 2H), 7.03 (tt, J ) 9, 2 Hz, 2H), 7.16 (AB, dt, J ) 9, 2 Hz,
2H), 7.21 (ABX, dd, J ) 9, 5.5 Hz, 2H). 13C NMR (300 MHz, CDCl3)
δ: 30.98, 38.31, 40.21, 51.06, 55.64, 114.61, 115.65 (d, J ) 19 Hz,
2C), 127.41, 128.01 (d, J ) 8 Hz, 2C), 135.74, 139.08 (d, J ) 3 Hz,
2C), 158.19, 161.60 (d, J ) 244 Hz, 2C), 169.16. IR (neat film, cm-1):
1642, 1511, 1266. Elemental analysis: %C (calc.) ) 72.22, %C
(found) ) 72.22, %H (calc.) ) 6.06, %H (found) ) 6.05. RD (589 nm,
12.8 mg/mL CHCl3) ) +8.
Acknowledgment. We thank the National Institutes of Health
(GM 46059) for funding and Pfizer, Merck, and Bristol-Myers
Squibb for additional unrestricted support. G.H. thanks the
Natural Sciences and Engineering Research Council (NSERC)
of Canada for a postdoctoral fellowship. We are grateful to Dr.
Rudy Schmid (Roche) for a generous gift of (S)-BIPHEMP.
We also thank Prof. Jeff Stryker for helpful comments.
(25) Spectral data and optical rotation were consistent with literature values.
1H/13C NMR: Roeder, E.; Krauss, H. Liebigs Ann. Chem. 1992, 177. Optical
rotation: Kosugi, H.; Tagami, K.; Takahashi, A.; Kanna, H.; Uda, H. J.
Chem. Soc., Perkin Trans. 1 1989, 935.
(26) Spectral data and optical rotation were consistent with literature values.
1H/13C NMR: Kayser, M. M.; Chen, G.; Stewart, J. D. J. Org. Chem. 1998,
63, 7103. Optical rotation: Jones, J. B.; Lok, K. P. Can. J. Chem. 1979,
57, 1025.
Supporting Information Available: Preparation and charac-
terization of all substrates and products (PDF). This material is
JA0351692
9
11258 J. AM. CHEM. SOC. VOL. 125, NO. 37, 2003